We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About AKASA Stock

Invest in or calculate the value of your shares in AKASA or other pre-IPO companies through EquityZen's platform.

Get Started

AKASA Stock (AKAS)

AKASA is an AI-powered automation company for revenue cycle management in healthcare.

About AKASA Stock

Founded

2018

Headquarters

San Francisco, CA, US

Industries

Software, Data and Analytics, Artificial Intelligence

AKASA is the leading developer of AI-powered automation for the revenue cycle. We deliver comprehensive automation for complex workflows. This helps healthcare providers improve revenue outcomes, achieve greater efficiency, elevate their teams, and allocate resources where they matter most. From prior authorization to claims processing, we provide innovative and reliable revenue cycle solutions that give providers peace of mind. AKASA applies advanced technology (such as AI and LLMs) to automate revenue cycle tasks that are complex and time-consuming, and were previously un-solvable at scale. Our solutions are built on deep revenue cycle expertise, grounded in the highest standards for data security, and provide measurable results with accuracy, speed, and completeness. We’ve helped healthcare providers decrease A/R days by 13%, increase efficiency by 86%, save 300+ hours of staff time per month, and increase gross yield by $30M. With investors that include Andreessen Horowitz, BOND, Costanoa Ventures, and more, we’ve raised more than $200M to help eliminate the financial complexity of healthcare. We’re rebuilding the healthcare revenue cycle with AI.

AKASA Management

Leadership team at AKASA

Co-Founder and CEO

Malinka Walaliyadde

Co-Founder & Chief Technology Officer

Varun Ganapathi

Locked Features

Join now and verify your accreditation status to gain access to:

  • AKASA current valuation
  • AKASA stock price
  • Available deals in AKASA and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in AKASA stock?

Accredited investors can buy pre-IPO stock in companies like AKASA through EquityZen funds. These investments are made available by existing AKASA shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell AKASA stock?

Shareholders can sell their AKASA stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."